Brand Name: SGONEK
Price: $150 -$250/Kilogram
Place of Origin: Shaanxi, China
Certification: ISO FDA SG COA MSDS
Grade: Food Grade Pharmaceutical Grade
Payment Terms: T/T, Western Union, MoneyGram
Product Name: | Adenosine | Cas No.: | 56-65-5 |
Molecular Formula: | C10H16N5O13P3 | Purity: | 99%min |
Brand Name: | SGONEK | Certification: | ISO FDA SG COA MSDS |
Product Name | Adenosine Triphosphate |
CAS No. | 56-65-5 |
Purity | 99% |
Appearance | White Crystalline Powder |
Molecular Formula | C10H16N5O13P3 |
EINECS No. | 200-283-2 |
Description: Adenosine Triphosphate Disodium (ATP) is the abbreviation of the English name. The structure of ATP molecules can be abbreviated as AP ~ P ~ P, where A representative of adenosine, P behalf of phosphate groups, ~ represents a particular chemical bond, called the high-energy phosphate bond, high-energy phosphate bond cleavage, the large amount of energy is released out. |
Items | Specification | Test Result |
Content (on drysis) |
≥95.0% | 98.5% |
Purity |
≥98.0% |
99.1% |
Physical &Chemical Control | ||
Appearance |
White Crystalline Powder |
Complies |
PH |
2.5-3.5 |
3.0 |
Water Content |
6.0%~12.0% |
9.4% |
Related Substance |
≤5.0% | 1.8% |
Chloride (CL) |
≤0.05% |
<0.05% |
Iron Salt |
≤0.001% |
0.001% |
Heavy Metals | ||
As |
≤1.0ppm |
<1.0ppm |
Heavy Metals | ≤10ppm | <10ppm |
Fe | ≤10ppm | <10ppm |
Microbiological Control | ||
Total Plate Count | ≤1000cfu/g | 80cfu/g |
Yeast & Mold | ≤100cfu/g | <10cfu/g |
E.Coli | Negative | Negative |
Salmonella | Negative | Negative |
Staphylococcus aureus |
Negative | Negative |
Conclusion | Conform with specification, Non-GMO, Allergen Free, TSE/BSE Free. | |
Storage | Stored in cool & dry place,keep away from strong light & heat. | |
Shelf Life |
Two Years when stored properly. |
Adenosine Triphosphate Disodium (ATP) is used as Pharmaceutical Raw Material.
Adenosine Triphosphate Disodium (ATP) can be used in the disease caused by tissue injury and activity reduction of ecto enzyme , including heart failure, carditis, miocardial infarction, cerebral arteriosclersis, coronary sclerosis, progressive muscular atrophy , cerebral hemorrhage , chronic hepatitis, cirrhosis of liver and hearing handicap, etc.